Investigating the Effect of Aloe vera Gel on the Buccal Permeability of Didanosine

Abstract ! The buccal mucosal route offers several advantages but the delivery of certain drugs can be limited by low membrane permeability. This study investigated the buccal permeability properties of didanosine (ddI) and assessed the potential of Aloe vera gel (AVgel) as a novel buccal permeation...

Full description

Bibliographic Details
Main Authors: Ojewole, E, Govender, T, Esley-Smith, J, Mackraj, I, Akhundov, K, Hamman, J, Viljoen, A, Olivier, E
Format: Others
Language:en
Published: Journal of Pharmacy and Pharmacology 2012
Subjects:
Online Access:http://encore.tut.ac.za/iii/cpro/DigitalItemViewPage.external?sp=1001725
Description
Summary:Abstract ! The buccal mucosal route offers several advantages but the delivery of certain drugs can be limited by low membrane permeability. This study investigated the buccal permeability properties of didanosine (ddI) and assessed the potential of Aloe vera gel (AVgel) as a novel buccal permeation enhancer. Permeation studies were performed using Franz diffusion cells, and the drug was quantified by UV spectroscopy. Histomorphological evaluations were undertaken using light and transmission electron microscopy. The permeability of ddI was concentration-dependent, and it did not have any adverse effects on the buccal mucosae. A linear relationship (R2 = 0.9557) between the concentrations and flux indicated passive diffusion as the mechanism of drug transport. AVgel at concentrations of 0.25 to 2%w/v enhanced ddI permeability with enhancement ratios from 5.09 (0.25%w/v) to 11.78 (2%w/v) but decreased permeability at 4 and 6%w/v. Ultrastructural analysis of the buccal mucosae treated with phosphate buffer saline pH 7.4 (PBS), ddI/ PBS, and ddI/PBS/AVgel 0.5%w/v showed cells with normal plasmalemma, well-developed cristae, and nuclei with regular nuclear envelopes. However, cells from 1, 2, and 6%w/v AVgel-treated mucosae showed irregular nuclear outlines, increased intercellular spacing, and plasmalemma crenulations. This study demonstrates the potential of AVgel as a buccal permeation enhancer for ddI to improve anti-HIV and AIDS therapy.